Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01343901
What this trial is testing

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 210
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT01525056
What this trial is testing

Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI

Who this might be right for
Rectal Cancer
London Health Sciences Centre 30
Testing effectiveness (Phase 2)Study completedNCT03800602
What this trial is testing

Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer

Who this might be right for
Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaRefractory Colorectal Carcinoma+5 more
Emory University 29
Very early researchActive Not RecruitingNCT06011772
What this trial is testing

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Colo-rectal Cancer
Roswell Park Cancer Institute 2
Not applicableStudy completedNCT02175095
What this trial is testing

[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

Who this might be right for
Colorectal Cancer
Asan Medical Center 68
Testing effectiveness (Phase 2)Study completedNCT01991873
What this trial is testing

Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 387
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Early research (Phase 1)Study completedNCT02008383
What this trial is testing

Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
John Strickler, M.D. 29
Large-scale testing (Phase 3)Study completedNCT00063141
What this trial is testing

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,302
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134205
What this trial is testing

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai JMT-Bio Inc. 252
Early research (Phase 1)Looking for participantsNCT06833866
What this trial is testing

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Advanced or Metastatic CRC
The Methodist Hospital Research Institute 33
Early research (Phase 1)Study completedNCT00101894
What this trial is testing

Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer

Who this might be right for
Rectal CancerColon Cancer
Amgen 119
Large-scale testing (Phase 3)Study completedNCT00069095
What this trial is testing

Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 2,035
Testing effectiveness (Phase 2)Ended earlyNCT00120172
What this trial is testing

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Geriatric Oncology Consortium 40
Testing effectiveness (Phase 2)Study completedNCT00867334
What this trial is testing

New Individualized Therapy Trial for Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmColorectal Cancer
Inova Health Care Services 10
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Next Page